Successful price hike and monocarton initiatives to lead to favourable Ebitda.
Q2FY24 Ebitda exceeds estimates, driven by strong refining margins
In the second quarter of the fiscal year, retail sales showed remarkable growth, surging by 21% y-o-y and an impressive…
Medanta’s team of senior clinicians and nurses has effectively met the diverse therapeutic needs of a wide-ranging patient community, positioning…
Aiming for a 29% CAGR over the FY23-FY25 period
FMCG ad spending sparks optimism, festive season boost expected.
Expansion, efficiency, and demand recovery set to fuel growth
These investments could increase TCOM’s capex to $600 million.
DMART foresees strong recovery in same store sales growth
1,000+ offline pharmacy stores added in FY23.
Improved margin outlook is driven by lower input costs.
Expected to report 8% CAGR in consolidated volume in FY23-25
Plans higher growth rate, forecasts margins to surpass 5% for FY24
Bank aims to bring down the ratio to 2% in the medium term.
There will be no near-term catalyst from the JLR business.
The management boasts of one of the highest fleet utilisation rates in the world and expects it to further improve…
Company to address challenges for better stock market valuation.
Growth to be boosted by lower raw material costs and global segments.
